Cellcyte Genetics Corp (SHPN) financial statements (2020 and earlier)

Company profile

Business Address PMB189
BELLEVUE, WA 98006
State of Incorp. NV
Fiscal Year End December 31
SIC 2834 - Pharmaceutical Preparations (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in thousands)

12/31/2013
12/31/2012
ASSETS
Current Assets
Prepaid expense and other current assets9
Other undisclosed current assets9 
Total current assets:99
Noncurrent Assets
Other undisclosed noncurrent assets 16
Total noncurrent assets: 16
TOTAL ASSETS:926
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities208119
Accounts payable126 
Accrued liabilities82119
Debt32
Due to related parties141 
Other undisclosed current liabilities 214
Total current liabilities:351335
Noncurrent Liabilities
Long-term debt and lease obligation477 
Long-term debt, excluding current maturities477 
Total noncurrent liabilities:477 
Total liabilities:829335
Stockholders' equity
Stockholders' equity attributable to parent, including:(820)11,685
Common stock, share subscribed but unissued, subscriptions receivable(49)(49)
Additional paid in capital11,73411,734
Other undisclosed stockholders' equity attributable to parent(12,505) 
Total stockholders' equity:(820)11,685
Other undisclosed liabilities and equity (11,994)
TOTAL LIABILITIES AND EQUITY:926

Income statement (P&L) ($ in thousands)

12/31/2013
12/31/2012
Operating expenses(124)(133)
Other operating expense, net(40) 
Operating loss:(164)(133)
Interest and debt expense 750
Income (loss) before gain (loss) on sale of properties:(164)617
Other undisclosed net loss (31)
Net income (loss) available to common stockholders, diluted:(164)586

Comprehensive Income ($ in thousands)

12/31/2013
12/31/2012
Net income (loss):(164)586
Comprehensive income (loss), net of tax, attributable to parent:(164)586

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: